Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Suspension - Faron Pharmaceuticals Oy

30 Mar 2026 07:30

RNS Number : 5226Y
AIM
30 March 2026
 

NOTICE

 

30/03/2026 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

FARON PHARMACEUTICALS OY

 

At the request of the Company, trading on AIM for the under-mentioned securities was temporarily suspended from 30/03/2026 7:30am, pending an announcement.

 

SUBSCRIPTION RIGHTS, NIL PAID (DI)

(BS84X55) (FI4000602313)

If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0) 207 213 0880.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCJRMRTMTJTBIF
Date   Source Headline
21st Nov 20199:00 amRNSPrice Monitoring Extension
21st Nov 20197:15 amRNSApplication to Nasdaq First North Growth Market
19th Nov 201911:05 amRNSSecond Price Monitoring Extn
19th Nov 201911:00 amRNSPrice Monitoring Extension
15th Nov 201911:06 amRNSSecond Price Monitoring Extn
15th Nov 201911:00 amRNSPrice Monitoring Extension
12th Nov 20193:45 pmRNSRegistration of Shares
8th Nov 20197:00 amRNSResults of Placing and Issue Price
7th Nov 20194:51 pmRNSProposed Placing and Financial Adviser Appointment
5th Nov 20194:40 pmRNSSecond Price Monitoring Extn
5th Nov 20194:36 pmRNSPrice Monitoring Extension
5th Nov 20192:05 pmRNSSecond Price Monitoring Extn
5th Nov 20192:00 pmRNSPrice Monitoring Extension
5th Nov 201911:05 amRNSSecond Price Monitoring Extn
5th Nov 201911:00 amRNSPrice Monitoring Extension
5th Nov 20199:05 amRNSSecond Price Monitoring Extn
5th Nov 20199:00 amRNSPrice Monitoring Extension
4th Nov 20194:35 pmRNSPrice Monitoring Extension
4th Nov 20192:05 pmRNSSecond Price Monitoring Extn
4th Nov 20192:00 pmRNSPrice Monitoring Extension
1st Nov 20192:15 pmRNSStatement regarding Price Movement
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
1st Nov 201911:06 amRNSSecond Price Monitoring Extn
1st Nov 201911:00 amRNSPrice Monitoring Extension
31st Oct 20194:35 pmRNSPrice Monitoring Extension
25th Oct 20199:27 amRNSResults of EGM
11th Oct 20192:05 pmRNSSecond Price Monitoring Extn
11th Oct 20192:00 pmRNSPrice Monitoring Extension
9th Oct 20197:00 amRNSMatins Trial Update
4th Oct 20197:20 amRNSNotice of EGM
2nd Oct 20197:00 amRNSUpdate on Traumakine drug substance manufacturing
30th Sep 20197:00 amRNSMATINS poster presentation at ESMO Congress
25th Sep 20199:13 amRNSHoldings in Company
23rd Sep 20197:08 amRNSInterim results
2nd Sep 20197:00 amRNSMATINS study selected for ESMO 2019
27th Aug 20197:00 amRNSResult of Open Offer and Further Subscription
19th Aug 20199:33 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSNotice of Interim Results
6th Aug 20191:53 pmRNSIssue of Equity
5th Aug 20197:00 amRNSSubscription and Open Offer
12th Jul 20197:00 amRNSMATINS study update
5th Jul 20199:00 amRNSPrice Monitoring Extension
4th Jul 20194:40 pmRNSSecond Price Monitoring Extn
4th Jul 20194:35 pmRNSPrice Monitoring Extension
4th Jul 20192:00 pmRNSPrice Monitoring Extension
4th Jul 20199:31 amRNSHoldings in Company
1st Jul 201912:10 pmRNSGrant of options
26th Jun 20197:00 amRNSPhase II INFORAAA study update
14th Jun 20197:00 amRNSFinal results from YODA study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.